Dr. Amoroso is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-706-4613Fax+1 410-706-4619
Summary
- Anthony Amoroso, MD is an Infectious Disease specialist based in Baltimore, MD. He completed his medical education at Augusta University's Medical College of Georgia in 1995, followed by a residency in Internal Medicine at Tufts Medical Center and a fellowship in Infectious Disease at the University of Maryland. Dr. Amoroso has an extensive list of publications across various medical journals, such as Open Forum Infectious Diseases, Infection Control and Hospital Epidemiology, Pathogens, and The American Journal of Hospice & Palliative Care. His work primarily centers around infectious disease complications related to substance abuse and HIV treatment.
Education & Training
- University of MarylandFellowship, Infectious Disease, 1998 - 2000
- Tufts Medical CenterResidency, Internal Medicine, 1995 - 1998
- Medical College of Georgia at Augusta UniversityClass of 1995
Certifications & Licensure
- MD State Medical License 1999 - 2026
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 2 citationsPredictors of Nonadherence Among Patients With Infectious Complications of Substance Use Who Are Discharged on Parenteral Antimicrobial Therapy.Shivakumar Narayanan, Patrick R Ching, Edward C Traver, Nivya George, Anthony Amoroso
Open Forum Infectious Diseases. 2023-01-01 - 23 citationsChange in Hospital Antibiotic Use and Acquisition of Multidrug Resistant Gram-Negative Organisms After the Onset of Coronavirus Disease 2019.Jacqueline T. Bork, Surbhi Leekha, Kimberly C. Claeys, Hyunuk Seung, Megan Tripoli
Infection Control and Hospital Epidemiology. 2021-09-01 - 5 citationsSingle-Agent and Fixed-Dose Combination HIV-1 Protease Inhibitor Drugs in Fission Yeast (Schizosaccharomyces pombe).Jiantao Zhang, Kasey Vernon, Qi Li, Zsigmond Benko, Anthony Amoroso
Pathogens. 2021-06-24
Press Mentions
- Saved by the Season: Researchers Find Summer Sun’s Rays Kill Coronavirus ‘Relatively Fast’June 26th, 2020
- Researchers Use Climate to Predict Spread of COVID-19March 27th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: